通过k-fold交叉验证检查阿尔茨海默病多基因风险评分的表现

Michael D Osterman¹, Yeunjoo E Song¹, Audrey Lynn¹+10

• ¹From the Department of Population and Quantitative Health Sciences (M.D.O., Y.E.S., A.L., K.M., N.R.W., J.B., W.S.B., J.L.H.); Cleveland Institute for Computational Biology (M.D.O., Y.E.S., A.L., W.S.B., J.L.H.), Case Western Reserve University, OH; Department of Medicine (Biomedical Genetics) (L.A.F.), Boston University, Boston, MA; Penn Neurodegeneration Genomics Center (G.D.S.), Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia; The John P. Hussman Institute for Human Genomics (E.R.M., M.A.P.-V.), The University of Miami Miller School of Medicine; and Dr. John T. Macdonald Foundation Department of Human Genetics (E.R.M., M.A.P.-V.), University of Miami, Miami, FL.